Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Juanbi Qianggu Formula vs celecoxib for knee osteoarthritis (liver–kidney deficiency type)
ChiCTR2200061615Phase 4Suspended
- Sponsor
- Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
- Start
- Jun 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Juanbi Qianggu Formula and celecoxib in knee osteoarthritis (OA) (2 arms), sponsored by Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. Primary endpoint: Traditional Chinese Medicine Syndrome Score. Started Jun 2022; status: suspended.
02
Drugs
Juanbi Qianggu Formulacelecoxib
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2200061615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061615.